ALLIE LEDBETTER: Open Payments
NPI 1689374563 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 19 payments from 7 companies in 2025. Trend: 2023 $650 · 2024 $328 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
| Lundbeck LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Kerendia, CAPLYTA, SPRAVATO, REXULTI, IBSRELA, BREZTRI, MOUNJARO.
Industry payments across AL — which companies pay providers there.
